XBIO Xenetic Biosciences, Inc.

Xenetic Biosciences Inc is a clinical-stage biopharmaceutical company focused on the discovery, research and development of next-generation biologic drugs and novel orphan oncology therapeutics.

As of 04/13/2021     IEX book   CBOE book

Security Information
Category1:  US Equity
Category2:  Common stocks
Category3:  Micro cap
GICS sector:  Health Care
Industry:  Biotechnology
Index country:  USA
Country of incorporation:  
IPO date:  04/17/2014
Outstanding shares:  8,746,692
Average volume:  199,585
Market cap:   $17,930,719
Current dividend yield:  0.00%
All SEC filings:     SEC Edgar Online
Quarterly filings:   10-Q
Annual filings:      10-K
CUSIP:    984015206
Valuation   (See tab for details)
PE ratio:   -1.65
PB ratio:   1.47
PS ratio:   41.04
Return on equity:   -89.18%
Net income %:   -2,493.11%

2021 © Stock Market MBA, Inc. Terms of use | Privacy policy